Showing results (971-980 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|May 8, 2015
Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapyMd Selim Ahmed, Se Eun Byeon, Yideul Jeong, et al.Oncoimmunology|May 8, 2015
IFNγ producing CD8+ T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomasMichel Buferne, Lionel Chasson, Magali Grange, et al.Oncoimmunology|May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaJiang Li, Qiu-Yan Chen, Jia He, et al.Oncoimmunology|May 8, 2015
A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLCGuangbo Zhang, Haitao Huang, Yibei Zhu, et al.Oncoimmunology|May 8, 2015
PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growthParul Gupta, Stephen E Wright, Sanjay K SrivastavaOncoimmunology|May 8, 2015
BRAF-inhibition and tumor immune suppressionShannon M Steinberg, Mary Jo TurkOncoimmunology|May 8, 2015
Reducing toxicity of 4-1BB costimulation: targeting 4-1BB ligands to the tumor stroma with bi-specific aptamer conjugatesB Schrand, A Berezhnoy, R Brenneman, et al.Oncoimmunology|May 8, 2015
High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progressionDiana Costa Bento, Emma Jones, Syed Junaid, et al.Oncoimmunology|May 8, 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patientsM Christina Cox, Simone Battella, Raffaella La Scaleia, et al.Oncoimmunology|May 8, 2015
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective studyBenedikt Fritzsching, Joerg Fellenberg, Linda Moskovszky, et al.Pageof 379